Terrill Mcclanahan
Overview
Explore the profile of Terrill Mcclanahan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
7673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yearley J, Gibson C, Yu N, Moon C, Murphy E, Juco J, et al.
Clin Cancer Res
. 2017 Jun;
23(12):3158-3167.
PMID: 28619999
Tumor-associated PD-L1 expression is predictive of clinical response to PD-1-directed immunotherapy. However, PD-L1-negative patients may also respond to PD-1 checkpoint blockade, suggesting that other PD-1 ligands may be relevant to...
2.
Seiwert T, Burtness B, Mehra R, Weiss J, Berger R, Eder J, et al.
Lancet Oncol
. 2016 Jun;
17(7):956-965.
PMID: 27247226
Background: Patients with recurrent or metastatic squamous cell carcinoma of the head and neck have few treatment options. We aimed to assess the safety, tolerability, and antitumour activity of pembrolizumab,...
3.
IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis
Adamopoulos I, Suzuki E, Chao C, Gorman D, Adda S, Maverakis E, et al.
Ann Rheum Dis
. 2014 Feb;
74(6):1284-92.
PMID: 24567524
Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease characterised by clinical features that include bone loss and epidermal hyperplasia. Aberrant cytokine expression has been linked to joint and skin...
4.
Landheer J, Giovannone B, Mattson J, Tjabringa S, Bruijnzeel-Koomen C, Mcclanahan T, et al.
J Allergy Clin Immunol
. 2013 Oct;
132(5):1252-4.
PMID: 24112829
No abstract available.
5.
Emmerich J, Mumm J, Chan I, LaFace D, Truong H, Mcclanahan T, et al.
Cancer Res
. 2012 May;
72(14):3570-81.
PMID: 22581824
The presence of activated intratumoral T cells correlates clinically with better prognosis in patients with cancer. Although tumor vaccines can increase the number of tumor-specific CD8(+) T cells in systemic...
6.
Mumm J, Emmerich J, Zhang X, Chan I, Wu L, Mauze S, et al.
Cancer Cell
. 2011 Dec;
20(6):781-96.
PMID: 22172723
Tumor immune surveillance and cancer immunotherapies are thought to depend on the intratumoral infiltration of activated CD8(+) T cells. Intratumoral CD8(+) T cells are rare and lack activity. IL-10 is...
7.
Chen Y, Haines C, Gutcher I, Hochweller K, Blumenschein W, Mcclanahan T, et al.
Immunity
. 2011 Mar;
34(3):409-21.
PMID: 21435588
T helper 17 (Th17) cell development is driven by cytokines including transforming growth factor-β (TGF-β), interleukin-6 (IL-6), IL-1, and IL-23. Regulatory T (Treg) cells can provide the TGF-β in vitro,...
8.
Desai B, Mattson J, Paintal H, Nathan M, Shen F, Beaumont M, et al.
Exp Lung Res
. 2011 Feb;
37(4):227-38.
PMID: 21309737
Idiopathic interstitial pneumonias are a group of idiopathic interstitial lung diseases of which idiopathic pulmonary fibrosis (IPF) is the lesion of usual interstitial pneumonia. Although the pathogenic mechanisms remain incompletely...
9.
Adamopoulos I, Chao C, Geissler R, LaFace D, Blumenschein W, Iwakura Y, et al.
Arthritis Res Ther
. 2010 Feb;
12(1):R29.
PMID: 20167120
Introduction: The interaction between the immune and skeletal systems is evidenced by the bone loss observed in autoimmune diseases such as rheumatoid arthritis. In this paper we describe a new...
10.
Kleinschek M, Muller U, Schutze N, Sabat R, Straubinger R, Blumenschein W, et al.
Int Immunol
. 2009 Dec;
22(2):81-90.
PMID: 19951959
IL-23 is a key cytokine in promotion of chronic inflammation. Here, we address if its pro-inflammatory potential can be harnessed to protect against chronic cryptococcosis. Mice were infected with Cryptococcus...